Vanguard Group’s Amneal Pharmaceuticals AMRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$142M Buy
17,551,391
+1,788,664
+11% +$14.5M ﹤0.01% 1671
2025
Q1
$132M Buy
15,762,727
+920,758
+6% +$7.72M ﹤0.01% 1669
2024
Q4
$118M Buy
14,841,969
+218,025
+1% +$1.73M ﹤0.01% 1801
2024
Q3
$122M Buy
14,623,944
+629,766
+5% +$5.24M ﹤0.01% 1782
2024
Q2
$88.9M Buy
13,994,178
+265,945
+2% +$1.69M ﹤0.01% 1889
2024
Q1
$83.2M Buy
13,728,233
+85,846
+0.6% +$520K ﹤0.01% 1956
2023
Q4
$82.8M Buy
13,642,387
+94,087
+0.7% +$571K ﹤0.01% 1953
2023
Q3
$57.2M Buy
13,548,300
+412,599
+3% +$1.74M ﹤0.01% 2067
2023
Q2
$40.7M Sell
13,135,701
-141,715
-1% -$439K ﹤0.01% 2279
2023
Q1
$18.5M Buy
13,277,416
+229,348
+2% +$319K ﹤0.01% 2616
2022
Q4
$26M Buy
13,048,068
+213,723
+2% +$425K ﹤0.01% 2502
2022
Q3
$25.9M Buy
12,834,345
+181,885
+1% +$367K ﹤0.01% 2519
2022
Q2
$40.2M Sell
12,652,460
-177,912
-1% -$566K ﹤0.01% 2296
2022
Q1
$53.5M Buy
12,830,372
+1,255,477
+11% +$5.24M ﹤0.01% 2269
2021
Q4
$55.4M Buy
11,574,895
+315,036
+3% +$1.51M ﹤0.01% 2290
2021
Q3
$60.1M Sell
11,259,859
-236,808
-2% -$1.26M ﹤0.01% 2261
2021
Q2
$58.9M Buy
11,496,667
+391,756
+4% +$2.01M ﹤0.01% 2278
2021
Q1
$74.7M Buy
11,104,911
+122,080
+1% +$822K ﹤0.01% 2103
2020
Q4
$50.2M Buy
10,982,831
+216,548
+2% +$990K ﹤0.01% 2201
2020
Q3
$41.8M Sell
10,766,283
-468,689
-4% -$1.82M ﹤0.01% 2104
2020
Q2
$53.5M Buy
11,234,972
+493,568
+5% +$2.35M ﹤0.01% 1982
2020
Q1
$37.4M Buy
10,741,404
+556,329
+5% +$1.94M ﹤0.01% 1996
2019
Q4
$49.1M Buy
10,185,075
+715,341
+8% +$3.45M ﹤0.01% 2114
2019
Q3
$27.5M Sell
9,469,734
-287,894
-3% -$835K ﹤0.01% 2321
2019
Q2
$70M Buy
9,757,628
+218,497
+2% +$1.57M ﹤0.01% 1939
2019
Q1
$135M Buy
9,539,131
+434,069
+5% +$6.15M 0.01% 1581
2018
Q4
$123M Sell
9,105,062
-102,916
-1% -$1.39M 0.01% 1554
2018
Q3
$204M Buy
9,207,978
+465,375
+5% +$10.3M 0.01% 1370
2018
Q2
$143M Buy
+8,742,603
New +$143M 0.01% 1574